Edesa Biotech, Inc. Made Big Gain

Edesa Biotech, Inc. (EDSA:NASDAQ) rocketted at $1.51, representing a gain of 68%. On Tue, Feb 24, 2026, EDSA:NASDAQ touched a New 2-Week High of $1.51. The stock got featured on our News Catalysts scanner on Tue, Feb 24, 2026 at 11:27 AM in the 'BIOTECH' category. From Tue, Feb 10, 2026, the stock recorded 55.56% Up Days and 30.00% Green Days

About Edesa Biotech, Inc. (EDSA:NASDAQ)

Stellar Biotechnologies Inc is a biotechnology company. The company is engaged in the aquaculture, research, and development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein with an extensive history of safe and effective use in immunological applications. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-targeting agent to create immunotherapies for the treatment of a variety of diseases. It derives its revenues mostly from Europe. Stellar primarily market and distribute products directly to biotechnology and pharmaceutical companies, academic institutions, clinical research organizations, and research centers.